PRTK Annual Retained Earnings
-$930.45 M
-$63.57 M-7.33%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual retained earnings is -$930.45 million, with the most recent change of -$63.57 million (-7.33%) on December 31, 2022. During the last 3 years, it has fallen by -$219.19 million (-30.82%).PRTK Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly Retained Earnings
-$965.14 M
-$14.55 M-1.53%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly retained earnings is -$965.14 million, with the most recent change of -$14.55 million (-1.53%) on June 30, 2023. Over the past year, it has dropped by -$62.73 million (-6.95%).PRTK Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.3% | -7.0% |
| 3 y3 years | -30.8% | -26.7% |
| 5 y5 years | -97.9% | -82.9% |
PRTK Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | >+9999.0% | +2443.6% |
Paratek Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | -$965.14 M(+1.5%) |
| Mar 2023 | - | -$950.59 M(+2.2%) |
| Dec 2022 | -$930.45 M(+7.3%) | -$930.45 M(+0.8%) |
| Sept 2022 | - | -$923.29 M(+2.3%) |
| June 2022 | - | -$902.41 M(+2.0%) |
| Mar 2022 | - | -$884.79 M(+2.1%) |
| Dec 2021 | -$866.88 M(+7.3%) | -$866.88 M(+3.9%) |
| Sept 2021 | - | -$834.63 M(+2.2%) |
| June 2021 | - | -$816.43 M(-1.2%) |
| Mar 2021 | - | -$826.14 M(+2.3%) |
| Dec 2020 | -$807.80 M(+13.6%) | -$807.80 M(+3.2%) |
| Sept 2020 | - | -$782.79 M(+2.7%) |
| June 2020 | - | -$761.93 M(+3.1%) |
| Mar 2020 | - | -$738.88 M(+3.9%) |
| Dec 2019 | -$711.26 M(+22.1%) | -$711.26 M(+4.0%) |
| Sept 2019 | - | -$683.89 M(+5.0%) |
| June 2019 | - | -$651.28 M(+5.4%) |
| Mar 2019 | - | -$618.08 M(+6.1%) |
| Dec 2018 | -$582.47 M(+23.9%) | -$582.47 M(+4.1%) |
| Sept 2018 | - | -$559.68 M(+6.1%) |
| June 2018 | - | -$527.59 M(+6.0%) |
| Mar 2018 | - | -$497.86 M(+5.9%) |
| Dec 2017 | -$470.11 M(+23.6%) | -$470.11 M(+4.9%) |
| Sept 2017 | - | -$448.22 M(+5.0%) |
| June 2017 | - | -$426.89 M(+4.4%) |
| Mar 2017 | - | -$408.71 M(+7.5%) |
| Dec 2016 | -$380.36 M(+41.5%) | -$380.36 M(+7.5%) |
| Sept 2016 | - | -$353.91 M(+7.2%) |
| June 2016 | - | -$330.28 M(+10.1%) |
| Mar 2016 | - | -$300.00 M(+11.6%) |
| Dec 2015 | -$268.73 M(+35.8%) | -$268.73 M(+8.5%) |
| Sept 2015 | - | -$247.62 M(+10.4%) |
| June 2015 | - | -$224.20 M(+7.5%) |
| Mar 2015 | - | -$208.50 M(+5.4%) |
| Dec 2014 | -$197.87 M | -$197.87 M(+28.6%) |
| Sept 2014 | - | -$153.89 M(+5.6%) |
| June 2014 | - | -$145.69 M(+2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | -$142.36 M(+2.0%) |
| Dec 2013 | -$139.56 M(+24.5%) | -$139.56 M(+4.1%) |
| Sept 2013 | - | -$134.02 M(+3.6%) |
| June 2013 | - | -$129.32 M(+5.5%) |
| Mar 2013 | - | -$122.61 M(+9.4%) |
| Dec 2012 | -$112.11 M(+12.0%) | -$112.11 M(+6.2%) |
| Sept 2012 | - | -$105.56 M(-4.4%) |
| June 2012 | - | -$110.41 M(+4.9%) |
| Mar 2012 | - | -$105.27 M(+5.2%) |
| Dec 2011 | -$100.09 M(+4.0%) | -$100.09 M(-5.0%) |
| Sept 2011 | - | -$105.39 M(+5.0%) |
| June 2011 | - | -$100.40 M(+2.3%) |
| Mar 2011 | - | -$98.15 M(+2.0%) |
| Dec 2010 | -$96.21 M(+10.7%) | -$96.21 M(+2.8%) |
| Sept 2010 | - | -$93.58 M(+3.0%) |
| June 2010 | - | -$90.81 M(+2.3%) |
| Mar 2010 | - | -$88.75 M(+2.1%) |
| Dec 2009 | -$86.91 M(+33.5%) | -$86.91 M(+2.8%) |
| Sept 2009 | - | -$84.57 M(+4.7%) |
| June 2009 | - | -$80.76 M(+9.7%) |
| Mar 2009 | - | -$73.65 M(+13.1%) |
| Dec 2008 | -$65.11 M(-47.5%) | -$65.11 M(-23.3%) |
| Sept 2008 | - | -$84.84 M(+8.8%) |
| June 2008 | - | -$77.96 M(-37.7%) |
| Mar 2008 | - | -$125.07 M(+0.9%) |
| Dec 2007 | -$123.91 M(+35.6%) | -$123.91 M(+2.2%) |
| Sept 2007 | - | -$121.28 M(+2.7%) |
| June 2007 | - | -$118.04 M(+15.7%) |
| Mar 2007 | - | -$102.02 M(+11.6%) |
| Dec 2006 | -$91.38 M(+48.0%) | -$91.38 M(+9.4%) |
| Sept 2006 | - | -$83.56 M(+9.1%) |
| June 2006 | - | -$76.62 M(+10.7%) |
| Mar 2006 | - | -$69.22 M(+12.1%) |
| Dec 2005 | -$61.75 M(+62.7%) | -$61.75 M(+62.7%) |
| Dec 2004 | -$37.94 M(+425.8%) | -$37.94 M |
| Dec 2002 | -$7.22 M(+356.5%) | - |
| Dec 2001 | -$1.58 M | - |
FAQ
- What is Paratek Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual retained earnings year-on-year change?
- What is Paratek Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly retained earnings year-on-year change?
What is Paratek Pharmaceuticals annual retained earnings?
The current annual retained earnings of PRTK is -$930.45 M
What is the all time high annual retained earnings for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual retained earnings is -$1.58 M
What is Paratek Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, PRTK annual retained earnings has changed by -$63.57 M (-7.33%)
What is Paratek Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of PRTK is -$965.14 M
What is the all time high quarterly retained earnings for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly retained earnings is -$37.94 M
What is Paratek Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, PRTK quarterly retained earnings has changed by -$62.73 M (-6.95%)